PV

Pammi Verma

Active Director Director DIN 09858405
DIN 09858405 First appointment Jan 2023 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value •••• Premium profile

About Pammi Verma

Data last updated:

Pammi Verma is a Director at Prickly Biotech Pharma Private Limited (since 2023). The company operates in Chemicals. Prickly Biotech Pharma Private Limited reported revenue of ₹31.6 Lakh (FY 2024).

DIN 09858405
Primary Designation Director
Industry Chemicals
First Appointment 11 Jan 2023
Oldest Company Age 3 yrs
Largest company Prickly Biotech Pharma Private Limited · ₹31.6 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Jan 20232023₹31.6 Lakh (FY 2024)Active

Board colleagues of Pammi Verma

Directorship timeline

Open interactive timeline →
Prickly Biotech Pharma Private Limited
Premium access

Shareholding and investment profile for Pammi Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pammi Verma

Pammi Verma currently holds 1 directorship: Prickly Biotech Pharma Private Limited (Director, since 11 Jan 2023, revenue ₹31.6 Lakh (FY 2024)).

Pammi Verma was first appointed on 11 Jan 2023 as Director at Prickly Biotech Pharma Private Limited.

The current boards of Pammi Verma's companies include Astik Verma (Prickly Biotech Pharma Private Limited), Itendra Kumar Verma (Prickly Biotech Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available